Moderated by Olivier Leclerc, senior partner at McKinsey & Company, who in recent years led the firm’s digital analytics practice in pharma/biotech, the roundtable drew on expert insights from a panel composed of pharma chief digital officers, chief information officers, and other leaders in the digital space to explore three broad themes: 1) how to scale an organization’s digital transformation; 2) the capability and talent required to support that digital transformation; and 3) defining and optimizing the role of the chief digital officer (CDO). Presented here are highlights of the discussion.

Olivier Leclerc:What would you say are barriers to scaling up digital and analytics transformation in your organizations, and how do you see them being potentially overcome in the next few years?

Francesca Wuttke: I think one of the greatest barriers is the way pharmaceutical companies are structured themselves. We have a lot of domain…

Read more…

Share.

Comments are closed.